Medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) mimic this hormone to produce 15-22.5% body weight reduction in clinical trials
ECRI and ISMP released a joint white paper raising patient safety concerns about compounded peptide products widely marketed to consumers as wellness therapies for muscle building, anti-aging, injury recovery, and immune support
Although there have been positive outcomes in lab tests, both peptides are research chemicals, with their effectiveness and patient safety in humans not fully proven
note the peptide's favorable tolerability profile across multiple rodent studies, with no reported organ toxicity at research doses [1,2]
The first month of compounded semaglutide costs $149